Mastery EAQ Ch. 35

A  Tamsulosin

B  Minoxidil

C  Dutasteride

D  Stanozolol

A  Topical peripheral vasodilators

B  Androgens

C  Alpha1-adrenergic blockers

D  5-Alpha reductase inhibitors

A  Dysuria

B  Benign prostatic hyperplasia

C  Back pain

D  Gastrointestinal upset

A  Testosterone

B  Goserelin

C  Doxazosin

D  Minoxidil

A  Schedule II

B  Schedule III

C  Schedule IV

D  Schedule I

A  Tamsulosin

B  Sildenafil

C  Finasteride

D  Doxazosin

A  Infertility

B  Baldness

C  Hypertension

D  Benign prostate hyperplasia (BPH)

A  Hypotension

B  Peliosis of the liver

C  Loss of libido

D  Depression

A  Hemoglobin

B  Glucose

C  Hematocrit

D  Liver function

A  Neurogenic bladder

B  Renal calculi

C  Urinary tract infection

D  Benign prostatic hyperplasia

A  Nitrates

B  Antibiotics

C  Alpha agonists

D  Anticoagulants

A  White blood cell (WBC) count, Comprehensive metabolic panel

B  Blood glucose, Comprehensive metabolic panel

C  Lipid panel, Liver function tests (LFTs)

D  White blood cell (WBC) count, Blood glucose

A  “Both medications have a rapid onset of action and work together to alleviate the obstruction.”

B  “These drugs work together to shrink tissue in the prostate, relieving the obstruction.”

C  “Finasteride takes 6 months to work, whereas tamsulosin begins working immediately.”

D  “Tamsulosin alleviates the antiandrogen effects that are caused by finasteride.”

A  Impotence, Dizziness

B  Impotence, Urinary frequency

C  Dyspnea, Chest pain

D  Dizziness, Urinary frequency

A  Gastroesophageal reflux

B  Enlarged prostate

C  Fasting blood glucose 110 mg/dL

D  Creatinine 2.5 mg/dL

A  Report erections longer than 4 hours

B  Normal dose is 10 mg

C  Can take medication twice daily

D  Take drug 2 hours before sexual activity

A  Lisinopril

B  Citalopram

C  Saw palmetto

D  Hydrochlorothiazide

A  Infertility, Cardiovascular disorder

B  Muscle atrophy, Malabsorption syndrome

C  Anemia, Malabsorption syndrome

D  Muscle atrophy, Anemia

A  Increased hair growth, Reduction of prostate size

B  Bradycardia, Libido enhancement

C  Impotence, Bradycardia

D  Libido enhancement, Impotence

A  Call the health care provider to change the prescription.

B  Instruct the patient to take all cardiac medications first.

C  Assess the patient’s blood pressure.

D  Perform a thorough history, including medication.

A  A patient with severe burns over 70% of the body

B  A patient with AIDS

C  A patient with catabolism after major abdominal surgery

D  A high school athlete who has difficulty gaining weight

A  “I will take the tablet 1 hour before intercourse.”

B  “I will apply it onto the scrotal skin.”

C  “I will apply it to my abdomen.”

D  “I will push the suppository into my urethra.”

A  Review liver function tests

B  Assess skin integrity

C  Calculate 24-hour output

D  Obtain blood pressure

A  “Oral testosterone lasts no more than 12 hours.”

B  “Injectable testosterone has a longer duration of action.”

C  “Transdermal systems can be used but must be changed weekly.”

D  “Underarm spray form requires twice-daily application.”

A  Atorvastatin

B  Metformin

C  Finasteride

D  Isosorbide mononitrate

A  Helps in development of facial hair in men, Triggers better metabolic bodily functions, Triggers erectile dysfunction (ED)

B  Helps in production of red blood cells, Helps in development of facial hair in men, Helps develop the male sex characteristics

C  Triggers better metabolic bodily functions, Triggers erectile dysfunction (ED), Helps in production of red blood cells

D  Triggers better metabolic bodily functions, Helps develop the male sex characteristics, Triggers erectile dysfunction (ED)

A  Liver disorders, Hypothyroidism

B  Hypoglycemia, Liver disorders

C  Erectile dysfunction, Pulmonary hypertension

D  Hypothyroidism, Hypoglycemia

A  Oligospermia, Hypogonadism, Renal disease

B  Oligospermia, Pregnancy, Hypogonadism

C  Pregnancy, Renal disease, Hepatic disease

D  Hepatic disease, Oligospermia, Hypogonadism

A  The patient verbalizes the ability to maintain an erection.

B  The patient does not have dry mouth, nausea, or vomiting.

C  The patient’s blood pressure is 90/60 mm Hg.

D  The patient’s cardiac output is 5.6 L/min.

A  “Take your blood pressure before either medication.”

B  “Take the medications on opposite days.”

C  “Take the isosorbide mononitrate before the sildenafil.”

D  “Do not take the sildenafil.”

A  Excretion of sodium and potassium, Development of secondary sexual characteristics, Fat metabolism

B  Fat metabolism, Production of red blood cells, Excretion of sodium and potassium

C  Bone development, Production of red blood cells, Development of secondary sexual characteristics

D  Fat metabolism, Excretion of sodium and potassium, Bone development

A  Fluid retention

B  Peliosis of the liver

C  Roundness of face

D  Hirsutism

A  Anemia

B  Hyperacidity

C  Hypoglycemia

D  Fatty liver

A  Applies the patch on shaved skin

B  Replaces the patch every other day

C  Applies the patch on the scrotum

D  Applies the patch on clean, dry skin

A  Finasteride

B  Stanozolol

C  Tamsulosin

D  Minoxidil

A  Ultrasonography of the fetus

B  Exercise tolerance test

C  Lipid profile

D  Liver function test

A  Prostate cancer, Priapism

B  Endometriosis, Refractory anemias

C  Prostate cancer, Hypergonadism

D  Priapism, Hypergonadism

A  Metformin

B  Leuprolide

C  Doxycycline

D  Nitroglycerin

A  Euphoric effect

B  Pain relief

C  Stress relief

D  Muscle hypertrophy

A  Restoration of a full head of hair in 1 month

B  Stronger urinary stream without hesitancy

C  Increase in libido

D  Weight gain of 1 to 2 pounds per week

A  Back, Shoulder, Abdomen

B  Back, Thighs, Shoulder

C  Back, Thighs, Abdomen

D  Shoulder, Thighs, Abdomen

A  High class performers

B  Team athletes

C  Those often tardy

D  Those who do not socialize well

A  Hold the medication.

B  Measure testosterone levels.

C  Call the health care provider.

D  Continue to assess.

A  Is contraindicated for use in elderly patients

B  Causes hypotension if taken with nitroglycerin

C  Reduces the efficacy of nitroglycerin

D  May cause erectile dysfunction in patients

A  Prolonged erection

B  Fluid retention

C  Increased amount of ejaculate

D  Decreased libido

A  Scrotum

B  Upper arms

C  Thighs

D  Abdomen

A  Topical

B  Intramuscular

C  Transdermal

D  Oral

A  Minoxidil

B  Finasteride

C  Sildenafil

D  Methyltestosterone

A  Tachycardia

B  Changes in libido

C  Dermatitis

D  Chest pain

A  25 to 100 mg 1 hour before intercourse

B  50 to 400 mg by intramuscular injection

C  5 mg by mouth

D  1 mg by mouth

A  Finasteride

B  Minoxidil

C  Testosterone

D  Sildenafil

A  Reducing obstruction in the urethra

B  Improving erectile dysfunction

C  Increasing penile blood flow

D  Relaxing urine retention

A  Nitroglycerin

B  Furosemide

C  Famotidine

D  Ibuprofen

A  Relief from fluid retention

B  Enhancement of the male libido

C  Increased hair growth

D  Prolonged erection

A  Oral

B  Transdermal

C  Injection

D  Buccal

A  2 to 4 weeks

B  1 to 2 weeks

C  3 to 6 months

D  1 to 3 months

A  Goserelin

B  Nandrolone

C  Alfuzosin

D  Nilutamide